Investigación sobre el cáncer
AUTHORS
1Departments of Internal Medicine, Hematology/Oncology Division, Rogel Cancer Center,University of Michigan Medical Center, 2Department of Urology, Division of GU Oncology, Rogel Cancer Center,University of Michigan Medical Center, 3Departments of Surgery and Pathology, Perlmutter Cancer Center,NYU Langone Health
Autor
Institución
1Departments of Internal Medicine, Hematology/Oncology Division, Rogel Cancer Center,University of Michigan Medical Center, 2Department of Urology, Division of GU Oncology, Rogel Cancer Center,University of Michigan Medical Center, 3Departments of Surgery and Pathology, Perlmutter Cancer Center,NYU Langone Health
AUTHORS
1Department of Rheumatology, Ren Ji Hospital, School of Medicine,Shanghai Jiao Tong University, 2Department of Nephrology and Rheumatology,Yongchuan Hospital of Chongqing Medical University, 3Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College,Fudan University
Autor
Institución
1Department of Rheumatology, Ren Ji Hospital, School of Medicine,Shanghai Jiao Tong University, 2Department of Nephrology and Rheumatology,Yongchuan Hospital of Chongqing Medical University, 3Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College,Fudan University
AUTHORS
AUTHORS
AUTHORS
1Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies,Rutgers University, The State University of New Jersey, 2Graduate Program in Quantitative Biomedicine, School of Graduate Studies,Rutgers University, The State University of New Jersey, 3Department of Medicine, Division of Medical Oncology,Rutgers Robert Wood Johnson Medical School, 4Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, UCLA Metabolomics Center, and California NanoSystems Institute,David Geffen School of Medicine, University of California, Los Angeles, 5Mork Family Department of Chemical Engineering and Materials Science,University of Southern California, 6Pharmacology,Rutgers Robert Wood Johnson Medical School, 7Cancer Metabolism and Growth Program,Rutgers Cancer Institute of New Jersey
Autor
Institución
1Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies,Rutgers University, The State University of New Jersey, 2Graduate Program in Quantitative Biomedicine, School of Graduate Studies,Rutgers University, The State University of New Jersey, 3Department of Medicine, Division of Medical Oncology,Rutgers Robert Wood Johnson Medical School, 4Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center, UCLA Metabolomics Center, and California NanoSystems Institute,David Geffen School of Medicine, University of California, Los Angeles, 5Mork Family Department of Chemical Engineering and Materials Science,University of Southern California, 6Pharmacology,Rutgers Robert Wood Johnson Medical School, 7Cancer Metabolism and Growth Program,Rutgers Cancer Institute of New Jersey
AUTHORS
1Division of Pulmonary and Critical Care Medicine,University of California Los Angeles David Geffen School of Medicine, 2University of North Carolina at Chapel Hill, 3Department of Molecular and Medical Pharmacology,University of California Los Angeles, 4Andor Technology, 5Division of Orthopaedic Surgery,University of California Los Angeles David Geffen School of Medicine
Autor
Institución
1Division of Pulmonary and Critical Care Medicine,University of California Los Angeles David Geffen School of Medicine, 2University of North Carolina at Chapel Hill, 3Department of Molecular and Medical Pharmacology,University of California Los Angeles, 4Andor Technology, 5Division of Orthopaedic Surgery,University of California Los Angeles David Geffen School of Medicine
AUTHORS
AUTHORS